- Investing Ideas
- Danish Pharmaceuticals & Biotech Healthy potentially undervalued
Danish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
3
0 new
Companies which are potentially undervalued and in an acceptable financial position.
3 companies
Bavarian Nordic
Market Cap: DKK 14.0b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 183.50
7D
-3.7%
1Y
1.5%
H. Lundbeck
Market Cap: DKK 40.9b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 42.48
7D
-1.5%
1Y
22.0%
Novo Nordisk
Market Cap: DKK 1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 322.25
7D
-1.4%
1Y
-26.6%